Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of the current pandemic of the respiratory disease known as coronavirus disease 2019 (COVID-19). The government and health authorities around the world have advocated social distancing, containment measures, and effe...

Full description

Autores:

López Agudelo, Víctor Alonso
Gómez Ríos, David Andrés
Ramírez Malule, Howard

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/46006

Acceso en línea:

https://hdl.handle.net/10495/46006

Palabra clave:

COVID-19
SARS-CoV-2
Interferones
Interferons
Antivirales
Antiviral Agents
Lopinavir
Ritonavir
Cloroquina
Chloroquine
Hidroxicloroquina
Hydroxychloroquine
Bibliometría
Bibliometrics
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D000086402
https://id.nlm.nih.gov/mesh/D007372
https://id.nlm.nih.gov/mesh/D000998
https://id.nlm.nih.gov/mesh/D061466
https://id.nlm.nih.gov/mesh/D019438
https://id.nlm.nih.gov/mesh/D002738
https://id.nlm.nih.gov/mesh/D006886
https://id.nlm.nih.gov/mesh/D015706
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
ODS 9: Industria, innovación e infraestructura. Construir infraestructuras resilientes, promover la industrialización inclusiva y sostenible y fomentar la innovación

Rights

openAccess

License

http://creativecommons.org/licenses/by/4.0/